Investment
Features
FeesSafety
Academy
More
Pluang+

USANA's Glow supplement boosts skin brightness, radiance, and hydration in 12-week consumer study

Others
30 Jul 2026
PRNewsWire
View Source
Bullish
pluang ai news

USANA Health Sciences announced positive results from a 12-week consumer study of its Glow skincare supplement, showing over 97% of participants reported brighter, more radiant, and more even-toned skin. The study involved 36 participants from the US and Mexico, with additional benefits including improved hydration, firmness, and elasticity. Glow's formula includes ingredients like rose extract, vitamin C, and astaxanthin, designed to support skin health from within. These findings reinforce USANA's commitment to science-backed products that deliver visible skin improvements.

More News

Ferrari raises 2026 guidance after Q2 revenue and profit rise on strong personalization demand

Ferrari raises 2026 guidance after Q2 revenue and profit rise on strong personalization demand

Ferrari reported Q2 2026 net revenues of €1.94 billion, up 8% year-on-year, driven by a richer product mix and increased personalization sales. Operating profit rose 10% to €605 million with a margin of 31.2%, while net profit grew 9% to €463 million...

Company Fundamentals
Bullish
1 hour ago
Dimensional Fund Advisors discloses 1.58% stake in Gamma Communications PLC shares.

Dimensional Fund Advisors discloses 1.58% stake in Gamma Communications PLC shares.

Dimensional Fund Advisors Ltd. has publicly disclosed holding a 1.58% stake in Gamma Communications PLC as of July 29, 2026. The disclosure, made under Rule 8.3 of the Takeover Code, indicates ownership of 1,414,785 ordinary shares. This filing is a ...

Market News
Neutral
3 hours ago
Cellectar Biosciences to report Q2 2026 results and update on cancer drug development on Aug 13.

Cellectar Biosciences to report Q2 2026 results and update on cancer drug development on Aug 13.

Cellectar Biosciences will announce its financial results for Q2 ending June 30, 2026, and provide a corporate update on August 13, 2026. The company focuses on developing targeted cancer treatments using its proprietary drug delivery platform. Key p...

Company Fundamentals
Neutral
4 hours ago
Monster Beverage to report Q2 2026 earnings on August 6 with CEO call at 2 p.m. PT

Monster Beverage to report Q2 2026 earnings on August 6 with CEO call at 2 p.m. PT

Monster Beverage Corporation will release its financial results for the second quarter ending June 30, 2026, on August 6 after market close. CEO Hilton Schlosberg will host a conference call at 2 p.m. Pacific Time to discuss the company's performance...

Company Fundamentals
Neutral
4 hours ago
Leidos and CoreWeave partner to deliver secure AI cloud services for U.S. national security missions.

Leidos and CoreWeave partner to deliver secure AI cloud services for U.S. national security missions.

Leidos and CoreWeave have teamed up to provide secure, sovereign AI cloud services tailored for U.S. Intelligence Community and Department of War needs. This collaboration combines Leidos' expertise in mission-critical government systems with CoreWea...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App